Genetic Polymorphisms of <i>CYP2A6</i> in a Case-Control Study on Bladder Cancer in Japanese Smokers-Reference-Cited by-同舟云学术

Genetic Polymorphisms of CYP2A6 in a Case-Control Study on Bladder Cancer in Japanese Smokers

Published:2016 Issue:1 Volume:39 Page:84-89
ISSN:0918-6158
Container-title:Biological & Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Kumondai Masaki¹,Hosono Hiroki¹,Orikasa Kazuhiko²³,Arai Yoichi³,Arai Tomio⁴,Sugimura Haruhiko⁵,Ozono Seiichiro⁶,Sugiyama Takayuki⁶,Takayama Tatsuya⁶,Sasaki Takamitsu⁷,Hirasawa Noriyasu¹,Hiratsuka Masahiro¹

Affiliation:

1. Laboratory of Pharmacotherapy of Life-Style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University

2. Kesen-numa City Hospital

3. Department of Urology, Tohoku University

4. Department of Pathology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology

5. Department of Tumor Pathology, Hamamatsu University School of Medicine

6. Department of Urology, Hamamatsu University School of Medicine

7. Department of Environmental and Health Science, Tohoku Pharmaceutical University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/39/1/39_b15-00604/_pdf

Reference45 articles.

1. 1) Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin., 61, 69–90 (2011).

2. 2) National Cancer Center Japan. “Cancer mortality from Vital Statistics in Japan.”: ‹http://www.ganjoho.jp/en/index.html›, cited 31 July, 2015.

3. 3) Kakehi Y, Hirao Y, Kim WJ, Ozono S, Masumori N, Miyanaga N, Nasu Y, Yokomizo A. Bladder Cancer Working Group report. Jpn. J. Clin. Oncol., 40 (Suppl. 1), i57–i64 (2010).

4. 4) American Cancer Society. “Bladder Cancer Overview.”: ‹http://www.cancer.org/cancer/bladdercancer›, cited 31 July, 2015.

5. 5) Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. JAMA, 306, 737–745 (2011).

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymorphisms in drug-metabolizing genes and urinary bladder cancer susceptibility and prognosis: Possible impacts and future management;Gene;2024-05

2. Pharmacogenetics of Breast Cancer Treatments: A Sub-Saharan Africa Perspective;Pharmacogenomics and Personalized Medicine;2022-06

3. A review on the genetic polymorphisms and susceptibility of cancer patients in Bangladesh;Molecular Biology Reports;2022-03-11

4. A DNA adductome analysis revealed a reduction in the global level of C5-hydroxymethyl-2′-deoxycytidine in the non-tumoral upper urinary tract mucosa of urothelial carcinoma patients;Genes and Environment;2021-12

5. Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana;Pharmacogenomics and Personalized Medicine;2021-03